Search Results 951-960 of 17940 for Pathogens

  1. Publications - Shari A. Ochoa, M.D. - Mayo Clinic

    Characterization of Blood-borne Pathogen Exposures During Dermatologic Procedures: The Mayo Clinic Experience. Cutis. 2023 Mar; 111(3):143-145. View PubMed ...

  2. VE303 for Prevention of Recurrent Clostridioides Difficile Infection - Mayo Clinic

    The purpose of this study is to evaluate the safety and the Clostridioides difficile infection (CDI) recurrence rate at Week 8 in participants who receive a 14- ...

  3. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic's Center for Individualized Medicine is set to host its 13th Annual Individualizing Medicine Conference on Sept. 11-12 in Rochester, Minnesota.

  4. A Study of Immune Response to the Human Papillomavirus Vaccine in Young Women with Inflammatory Bowel Disease - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. Publications - Eric Chen, M.D., Ph.D. - Mayo Clinic

    A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and Phenotype. JAMA Netw Open. 2021 Feb 1; 4 (2):e210112 Epub 2021 ...

  6. Publications - Kimiyo M. Raymond, M.D. - Mayo Clinic

    ... Pathogenic Complex Allele. Front Genet. 2021; 12:777731 Epub 2021 Sept 30. View PubMed; Gonzalez-Dominguez CA, Fiesco-Roa MO, Gomez-Carmona S, Kleinert ...

  7. A Study Evaluating the Use of 48-hour Ambulatory EEG Monitoring in Early Onset Alzheimer’s Disease - Mayo Clinic

    Two or more first degree relatives with a history of EOAD suggestive of autosomal dominant transmission, unless known pathogenic mutations in APP, PSEN1, PSEN2 ...

  8. Crohn's disease - Doctors and departments - Mayo Clinic

    Radiologists at Mayo Clinic were instrumental in developing novel bowel imaging techniques, including magnetic resonance (MR) and CT enterography. Current ...

  9. Untitled

    Page 1.

  10. A Study to Evaluate Topical VT30 to Treat Patients with Venous/Lymphatic Malformations Associated with PIK3CA or TEK Gene Mutations - Mayo Clinic

    Lesion genotyping confirms either PIK3CA or TEK mutations, known to be pathogenic. Agrees to use contraception if of childbearing potential. Willing and ...